Related Experiment Video
Updated: May 7, 2026

13:14
Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Published on: February 6, 2018
Recombinant genetic libraries and human monoclonal antibodies
Jarrett J Adams1, Bryce Nelson, Sachdev S Sidhu
1Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada.
Methods in Molecular Biology (Clifton, N.J.)
|September 17, 2013
Summary
Researchers created synthetic antibody libraries using phage display to generate diverse human monoclonal antibodies. This method bypasses limitations of traditional antibody production, enabling precise manipulation of the human proteome.
Area of Science:
- Biotechnology
- Immunology
- Pharmacology
Background:
- Comprehensive manipulation of the human proteome requires a broad range of pharmacological reagents.
- Existing methods like hybridoma technology have limitations in antibody production.
Purpose of the Study:
- To develop synthetic antibody libraries for generating a vast repertoire of pharmacological reagents.
- To overcome limitations of hybridoma technology and improve antibody production parameters.
Main Methods:
- Utilizing phage display technology to create synthetic antibody libraries.
- Modifying complementarity-determining regions (CDRs) of a human antigen-binding fragment (Fab) scaffold with diversified oligonucleotides.
- Employing selection methodologies to overcome immuno-dominance and target multiple epitopes per antigen.
Main Results:
- Successfully produced synthetic antibody libraries from a single human framework with diversity in four CDRs.
- Generated highly selective, high-affinity Fabs against a majority of soluble human antigens.
- Demonstrated the ability to target a variety of epitopes per antigen through advanced selection techniques.
Conclusions:
- Synthetic antibody libraries offer a powerful platform for generating human monoclonal antibodies.
- This approach enables precise manipulation of the human proteome by overcoming limitations of conventional antibody discovery.
- The developed methodologies facilitate the production of functional antibodies for diverse therapeutic and research applications.
Related Concept Videos
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Recombinant DNA
Overview

